Skip to content
Events

Details

Illumina innovations are redefining the limits of next generation sequencing, enabling more insights, faster than ever. Join us for a half-day event as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series. We will walk through system specs and review key applications and methods.

Come and explore our fastest and simplest sequencer ever.

This page will be updated with registration links as new dates are confirmed.

May
June
  • Baltimore - June 4
  • Chicago - June 4
  • Columbus, Ohio - June 6
  • St. Louis - June 17
August
  • Atlanta - Aug. 8
  • Nashville - Aug. 28
September
  • Phoenix - date TBD
  • Los Angeles - date TBD
  • Dallas - date TBD
October
  • Philadelphia - date TBD
December
  • Cambridge, Mass. - Dec. 2
Date & Time
6 May 2025 – 2 Dec. 2025
Location
USA and Canada
Topic
Cellular & molecular biology, Microbial genomics, Oncology, Instruments

Related Events

Apr 23
Metagenomics: Introduction to library preparation and sequencing
Apr 23, 2025
This webinar provides a valuable platform to explore metagenomic sequencing, including an introduction to the concept, resources, techniques, sequencing approaches, and a high level overview of Illumina data analysis solutions.
View Event
Apr 25
American Association for Cancer Research (AACR) Annual Meeting 2025
Apr 25, 2025 – Apr 30, 2025
Join us at Illumina booth 800 to learn how Illumina is driving innovation in cancer research and clinical solutions.
View Event
Apr 30
Liquid Biopsy Applications From Illumina
Apr 30, 2025
Liquid biopsy allows non-invasive detection and analysis of tumor-derived biomarkers in body fluids like blood, urine, and saliva, aiding in early detection, therapy selection, and disease monitoring. Liquid biopsy has the potential to expands access to precision medicine in cases where tissue biopsies are unavailable, have low tumor content or fail quality control metrics. Illumina’s broad liquid biopsy portfolio includes Pillar small panels, TruSight Oncology500 ctDNA v2 for comprehensive genomic profiling, and even exome and whole genome sequencing. Find out how Illumina’s library prep uses dual-strand unique molecular indexing (UMIs) and the DRAGEN enrichment pipeline, to minimize the risk of false positive, and lower the limit of detection while maintaining high specificity
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.